DRI Healthcare Q2 total income rises

DRI Healthcare Trust

13/08/2025 23:32

Overview

DRI Healthcare Q2 total income at $44.1 mln, compared with 41.6 mln year ago

Co internalized investment management, aligning management with unitholders

Repurchased ~958K units for $9.1 mln under NCIB

Result Drivers

INTERNALIZATION - DRI Healthcare completed the internalization of its investment management function, aligning management with unitholders

EKTERLY INVESTMENT - Increased royalty entitlement on Ekterly by making a $22 mln optional payment, enhancing future cash flows

UNIT REPURCHASE - Repurchased ~958K units for $9.1 mln under NCIB, enhancing shareholder value

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Total Income
$44.13 mln
Q2 Adjusted Cash Earnings per Unit
$0.51
Q2 Net Earnings per Unit
$0.01
Q2 Net Income
$376,000
Q2 Adjusted EBITDA
$30.37 mln
Q2 Adjusted EBITDA Margin
76.0%


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the pharmaceuticals peer group is "buy"

Wall Street's median 12-month price target for Dri Healthcare Trust is C$19.25, about 22.3% above its August 13 closing price of C$14.95

Press Release: ID:nCNWMJ0F0a

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)